Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Abstract

loading...

About

This paper, published in 1950, received 745 indexed citations. Written by Hong Jiang, Samarth Hegde, Brett L. Knolhoff, Yu Zhu, John M. Herndon, Melissa A. Meyer, Timothy M. Nywening, William G. Hawkins, Irina M. Shapiro and David T. Weaver covering the research area of Oncology and Immunology. It is primarily cited by scholars working on Oncology (564 citations), Immunology (296 citations) and Molecular Biology (199 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm.4123 →

Countries where authors are citing Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Since Specialization
Citations

This map shows the geographic impact of Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy more than expected).

Fields of papers citing Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm.4123.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026